Streamline Blood Culture Collection And Augment Accuracy

According to the Centers for Disease Control and Prevention (CDC), sepsis is the leading cause of death in U.S. hospitals. As healthcare providers utilize blood culture tests to help determine a sepsis diagnosis, accurate results are key to patient survival.

Unfortunately, blood culture contamination rates range from 0.6% to 12.5%, leading to false positive results, misdiagnosis, and costly, delayed or inappropriate treatments including antibiotic misuse. False positive blood cultures affect patient safety, clinical outcomes, reimbursement and the hospital’s bottom line.¹

A study published in the Journal of Hospital Medicine showed that true negative results (87%) generated annualized costs of approximately $750,000. In comparison, false positives (6%) resulted in $1.4 – $1.8 million in annualized costs and added an average of 1,825 extra hospital days per year.²

The CDC states that “virtually all blood culture contamination occurs during collection.”³ False positives are preventable when standard operating procedures (SOP) are followed. With a national movement to lower the benchmark for blood culture contamination to less than 1%, SOP compliance is imperative.

The Blood Culture Collection Kit from C-Quest Streamlines Blood Culture Collection

Minimize false positive blood culture results and optimize efficiency with C-Quest Medical’s Blood Culture Collection Kit. As easy as 1,2,3, the three-pocket kit separates pre-collection, collection and post-collection contents to streamline the entire process and enhance compliance of standard operating procedures.

A sterile Initial Specimen Diversion Tube and a Sequestration Syringe are included in the procedure kit to assure reduced false positives and provide consistent, accurate blood culture results. Everything needed is in one place, at half the cost of competitive diversion devices alone.

C-Quest Blood Culture Collection Kit At-A-Glance

• Sterile Initial Specimen Diversion Tube minimizes blood culture contamination
• Sequestration Syringe provides safe and effective diversion
• Proper patient diagnosis and treatment are enhanced
• Antibiotic use and length of hospital stay are reduced
• 3-Pocket Kit configuration optimizes efficiency
• Costs no more than alternative collection methods without a diversion device
• Familiar components are easy to use and require virtually no training, optimizing compliance

References:

(1) Halstead, Diane C, et al. “Reducing Blood Culture Contamination Rates: Experiences of Four Hospital Systems.” Infectious Diseases and Therapy, U.S. National Library of Medicine, June 2020, www.ncbi.nlm.nih.gov/pmc/articles/PMC7237585/.

(2) RK;, Zwang O;Albert. “Analysis of Strategies to Improve Cost Effectiveness of Blood Cultures.” Journal of Hospital Medicine, U.S. National Library of Medicine, pubmed.ncbi.nlm.nih.gov/17219512/. Accessed 7 June 2024.

(3) United States, Department of Health and Human Services, Centers for Disease Control and Prevention. “Blood Culture Contamination: An Overview for Infection Control and Antibiotic Stewardship Programs Working with the Clinical Laboratory.” Centers for Disease Control and Prevention.

For more information about the Blood Culture Collection Procedure Kit or to request a demonstration, call 888-891-1200 or email us to be connected to a local representative.

MED Alliance Group is a medical device distributor that has been meeting the needs of our clinical customers and manufacturing partners since 1998. We specialize in the sales, marketing, importation, logistics and distribution of innovative, high-quality and cost-effective products found in anesthesia and respiratory, blood and transfusion therapy, EMS and emergency room, interventional radiology and cath lab, iv and vascular, NICU/PICU and pharmacy.

Please follow us on LinkedIn, Facebook and Twitter for MED Alliance product updates.